ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JUAN JOSE BAYRON M.D.

1791 CALLE ESTEBAN PADILLA URBANIZACION SANTIAGO IGLESIAS

San juan | Puerto Rico | 00921

(787) 783-0399

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 384

$466K Total Retail Price of All Prescriptions

Rank: 69 out of 384

702 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,804 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,317 1,154 1 1
ENALAPRIL MALEATE 983 794 2 6
METFORMIN HCL 844 711 3 2
LOSARTAN-HYDROCHLOROTHIAZIDE 587 536 4 10
ATENOLOL 536 488 5 12
LOSARTAN POTASSIUM 528 468 6 5
LEVOTHYROXINE SODIUM 526 447 7 11
GABAPENTIN 450 391 8 4
RANITIDINE HCL 445 370 9 7
OMEPRAZOLE 414 329 10 8
AMLODIPINE BESYLATE 362 336 11 3
ALENDRONATE SODIUM 311 256 12 20
SYNTHROID 289 240 13 9
GLIMEPIRIDE 282 231 14 18
GLIPIZIDE 279 233 15 27
MELOXICAM 269 216 16 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 246 221 17 78
FENOFIBRATE 219 180 18 53
HYDROCHLOROTHIAZIDE 214 199 19 16
PRAVASTATIN SODIUM 202 178 20 24
ZOLPIDEM TARTRATE 201 164 21 19
FUROSEMIDE 160 137 22 17
DICLOFENAC POTASSIUM 154 126 23 38
METOPROLOL TARTRATE 147 109 24 15
TRAMADOL HCL 135 87 25 40
DOXAZOSIN MESYLATE 132 123 26 29
ASPIRIN EC 127 109 27 31
LANTUS 125 97 28 42
CLOPIDOGREL 123 112 29 30
METOPROLOL SUCCINATE 105 97 30 21
ISOSORBIDE MONONITRATE ER 101 90 31 28
DONEPEZIL HCL 96 92 32 33
PLAVIX 92 88 33 32
AZITHROMYCIN 87 75 34 59
LISINOPRIL 87 81 34 14
VERAPAMIL ER 84 71 36 41
CLOTRIMAZOLE-BETAMETHASONE 84 61 36 58
LORATADINE 84 69 36 240
CARVEDILOL 82 67 39 23
PAROXETINE HCL 80 68 40 37
DIGOXIN 77 62 41 49
TAMSULOSIN HCL 77 63 41 25
SERTRALINE HCL 75 65 43 26
TRAMADOL HCL-ACETAMINOPHEN 75 60 43 13
JANUVIA 67 59 45 108
HUMULIN N 65 61 46 57
CIPROFLOXACIN HCL 64 54 47 50
CLONIDINE HCL 63 48 48 84
EVISTA 59 53 49 52
CENTRUM SILVER 59 39 49 438
ADVAIR DISKUS 56 44 51 65
NABUMETONE 54 42 52 34
SINGULAIR 52 30 53 63
CAPTOPRIL 51 44 54 72
CALTRATE 600 + D 51 45 54 196
GLYBURIDE-METFORMIN HCL 50 50 R 56 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.